Workshop C – Surveillance Best Practices for AYA Survivors of Childhood Cancer

Presentation Description: With the increased use of combination chemotherapy and multi-modality therapy for cancers that occur in childhood, many more children diagnosed with childhood malignancies are becoming long-term survivors.  Unfortunately, late effects of these treatments are common and have a significant impact on length and quality of life.  Identifying those adolescents and young adults at risk for specific late effects may allow for early intervention designed to minimize the impact of these health problems on the life of the survivor. This workshop focused on pulmonary, endocrine and renal late effects experience by adolescent and young adult survivors of childhood cancer.  Specific screening strategies and issues related to surveillance were discussed.

Workshop Facilitators:

Theodore K. Marras, MD, FRCPC, MSc
Toronto Western Hospital, University Health Network and Mount Sinai Hospital
Assistant Professor, Department of Medicine
University of Toronto

Stacey L. Urbach, MD, MPH, FRCPC
Staff, Division of Endocrinology
The Hospital for Sick Children
Assistant Professor, Department of Pediatrics
University of Toronto

Michael Zappitelli, MD, MSc
Director, Extracorporeal Blood Therapy & Peritoneal Dialysis Program
Pediatric Nephrology, Department of Pediatrics
McGill University Health Center
Montreal Children’s Hospital

Comments are closed.